HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kernan, K. Articles by Scully, M. Search for Related Content PubMed Articles by Kernan, K. Articles by Scully, M.

Methadone maintenance programmes

SouthWestern Area, Ireland, e-mail: kathykernan{at}eircom.net

Mike Scully, Consultant in Substance Misuse, Health Service Executive

SouthWestern Area, Ireland

Kumar & Rajwal (Psychiatric Bulletin, January 2006, 30, 16-18) raise issues related to the adequate dose of methadone for treatment of opioid dependence. They reported that 54% of patients who participated in the survey used opiates in addition of their prescribed methadone. It would have been relevant to know the doses of methadone that this group were receiving compared with those that did not report additional opiate use. Low-dose methadone treatment has been strongly associated with poor outcomes in clinical studies (Amato et al, 2005). Observational studies and randomised controlled trials indicate that there is a linear dose-response relationship between methadone dose and heroin use. The likelihood of using heroin decreases as the dose of methadone increases (Ward et al, 1998). Evidence suggests that the appropriate methadone dose during maintenance treatment should be between 60 and 120 mg/day for most people (Department of Health, 1999), with some requiring significantly higher doses and some patients stabilising on lower doses. The prescription of methadone doses in this range results in greater retention of patients in treatment programmes and less heroin use while in treatment.

We would argue that the evidence clearly indicates that optimising methadone dose on an individual basis may reduce the number of patients who continue to use opioids in addition to their prescribed methadone. We suggest that supervised daily consumption should be normal practice until the patient is stabilised.

References

AMATO, L., DAVOLI, M., PERUCCI, C., et al (2005) An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment, 28, 321 -329.[CrossRef][Medline]

DEPARTMENT OF HEALTH (1999) Drug Misuse and Dependence: Guidelines on Clinical Management. London:TSO (The Stationery Office). http://www.dh.gov.uk/assetRoot/04/07/81/98/04078198.pdf

WARD, J., MATTICK, R. P. & HALL, W. (1998) The use of methadone during maintenance treatment: pharmacology, dosage and treatment outcome. In Methadone Maintenance Treatment and Other Opioid Replacement Therapies (eds J. Ward, R. P. Mattick & W. Hall). Australia: Harwood Academic.

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kernan, K. Articles by Scully, M. Search for Related Content PubMed Articles by Kernan, K. Articles by Scully, M.